ArticleApoptosis : an international journal on programmed cell death2026
Ru3: a novel ruthenium-based compound overcomes cisplatin resistance in non-small cell lung cancer via the E2F2-IGFBP3-GPX4 pathway.
Yiting Lu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.